Ames National vs LCNB
ATLO and LCNB side by side, both in commercial banks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ATLO and LCNB compare
Ames National and LCNB are about the same size, with market caps of $300M and $280M.
On earnings, LCNB is cheaper: it trades at 11.2× trailing earnings, against 11.8× for Ames National.
Ames National grew revenue faster over the last twelve months (21.5% versus 7.4% for LCNB).
Ames National keeps more of each dollar of sales as profit, with a net margin of 33.3% compared with 25.5% at LCNB.
Both pay dividends: Ames National yields 2.7% and LCNB 4.5%.
LCNB scores higher on the StockData Score (17 against 16 for Ames National), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ATLO | LCNB |
|---|---|---|
| Size and price | ||
| Market cap | $300M | $280M |
| Share price | $33.86 | $19.66 |
| Change, 1 year | 59.2% | 26.9% |
| Change, 5 years | 37.5% | 0.51% |
| Beta (5Y) | 0.31 | 0.41 |
| Employees | 260 | 363 |
| StockData Score | ||
| Total score | 16 | 17 (better) |
| Valuation score | 2 | 4 (better) |
| Growth score | 2 (better) | 1 |
| Performance score | 5 (better) | 3 |
| Health score | 4 | 4 |
| Dividend score | 3 | 5 (better) |
| Valuation | ||
| P/E | 11.8× | 11.2× (better) |
| P/S | 3.9× | 2.9× (better) |
| P/B | 1.5× | 1.0× (better) |
| P/FCF | 13.4× | 8.5× (better) |
| FCF yield | 7.4% | 11.7% (better) |
| Fair value | $31.36 | $20.51 |
| Margin of safety | −8.0% | 4.1% (better) |
| Growth | ||
| Revenue growth (TTM) | 21.5% (better) | 7.4% |
| Revenue growth, 5Y average | 0.41% | 5.0% (better) |
| Net income growth (TTM) | 58.8% (better) | 5.6% |
| EPS growth (TTM) | 59.4% (better) | 5.4% |
| EPS growth, 5Y average | – | 1.0% |
| Profitability | ||
| Net margin | 33.3% (better) | 25.5% |
| FCF margin | 29.2% | 33.6% (better) |
| Return on equity | 12.5% (better) | 9.0% |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Altman Z-score | 0.27 (better) | 0.23 |
| Piotroski F-score | 7 (better) | 6 |
| Dividends and buybacks | ||
| Dividend yield | 2.7% | 4.5% (better) |
| Payout ratio | 32.0% | 50.3% |
| Years of dividend growth | 0 | 0 |
| Dividend growth, 5Y average | −4.4% | 3.8% (better) |
| Buyback yield | 0.24% (better) | −0.20% |
| Shareholder yield | 3.0% | 4.3% (better) |
| Ownership | ||
| Held by institutions | 40.9% | 50.3% |
| Held by insiders | 1.4% | 7.0% |
| Insider net buying, 12 months | $84.5K (better) | −$33.3K |
| Short interest, % of float | 2.5% | 0.94% |
Go deeper
- ATLO stock overview
- ATLO income statement
- ATLO valuation and score
- LCNB stock overview
- LCNB income statement
- LCNB valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.